Sha Zhao

机构：Nanchang University, Sichuan University, West China Hospital of Sichuan University, Second Affiliated Hospital of Nanchang University · ORCID：0000-0001-9347-7999

发表论文 127 篇 · 总被引 1499 次 · h-index 21

代表论文

• Multisystem ALK-positive histiocytosis: a multi-case study and literature review (2023 · Orphanet Journal of Rare Diseases · 被引 30)
• High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma (2023 · Frontiers in Immunology · 被引 14)
• RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification (2023 · Cancer Medicine · 被引 9)
• Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 7)
• Synergistic innovations of nanomedicine in lymphoma treatment: a systematic review (2025 · Journal of Translational Medicine · 被引 4)
• Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies (2023 · American Journal of Clinical Pathology · 被引 4)